" class="no-js "lang="en-US"> Drug Archives - Medtech Alert
Friday, June 21, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Biostar Pharma Announces First Patient Enrolled for Phase 1 Study of Utidelone Capsule (UTD2)--The World's First Oral Epothilone Anti-Cancer Drug

Biostar Pharma, the US subsidiary of Beijing Biostar Pharmaceuticals which is a synthetic biology-driven biopharma […]

Axol Bioscience Collaborates with StrataStem to Deliver Stem Cell-Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease

Axol Bioscience, a leading pluripotent stem cell technology provider for drug discovery has signed an […]

ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery

ClearPoint Neuro, a global therapy-enabling platform company providing navigation and delivery to the brain, today […]

CHARM Therapeutics Receives Investment for Deep Learning-Enabled Drug Discovery Research from NVIDIA

CHARM Therapeutics, a 3D deep-learning biotechnology company discovering and developing transformational medicines, today announced an […]

Areteia Therapeutics Announces Appointment of Elyse Stock, M.D. To Board of Directors

Areteia Therapeutics, today announced the appointment of Elyse Stock to the Areteia Board of Directors, […]

Merck & XtalPi Collaboration Optimizes Drug Formulations with AI-Powered Techniques

Science and technology company Merck and XtalPi, a pioneering pharmaceutical technology company powered by artificial […]

Kurve Therapeutics Announces Development of New Intellectual Property to Target Drug Delivery in the Brain

Today, Kurve Therapeutics announced it has filed for new intellectual property on its nose to […]

C4XD and Garvan Institute of Medical Research Report Successful Patient Stratification Approach Using C4XD's New Precision Medicine Platform PatientSeek

C4X Discovery Holdings (C4XD), a pioneering Drug Discovery company, announces the launch of a precision […]

Jnana Therapeutics Announces FDA Clearance of IND Application for JNT-517 for the Treatment of Phenylketonuria

Jnana Therapeutics, a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug […]

Sustained Therapeutics Advancing Clinical Trial for Novel Drug Delivery Platform

A Vancouver-based therapeutics company, Sustained Therapeutics, has received regulatory approval to begin the second Phase […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more